Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (18)flt Cpd
2. (18f)3'-deoxy-3'-fluorothymidine
3. (18f)flt
4. 1-(3'-fluoro-3'-deoxy-beta-d-erythropentofuranosyl)thymine
5. 18f-flt
6. 3'-(f-18)fluoro-3'-deoxythymidine
7. 3'-deoxy-3'-(18f)fluorothymidine
8. 3'-deoxy-3'-fluorothymidine
9. 3'-fluoro-2',3'-dideoxythymidine
10. 3'-fluoro-3'-deoxythymidine
11. 3'-fluorothymidine
12. Alovudine
13. Fddt
1. 18f-flt
2. Alovudine F-18
3. 3'-deoxy-3'-(18f)fluorothymidine
4. (18f)flt
5. Flt F-18
6. 287114-80-1
7. Thymidine, 3'-deoxy-3'-(18f)fluoro-
8. 2x1k91ut6n
9. [18f]flt
10. F-18 Fluorothymidine
11. Unii-2x1k91ut6n
12. 3'-deoxy-3'-18f-fluorothymidine
13. Schembl14461296
14. (18f) Flt
15. (18f)-flt
16. (f-18)flt
17. Dtxsid90182869
18. Db14930
19. Fluorothymidine (18f) [who-dd]
20. Q27255730
| Molecular Weight | 243.22 g/mol |
|---|---|
| Molecular Formula | C10H13FN2O4 |
| XLogP3 | -0.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 2 |
| Exact Mass | 243.088469 g/mol |
| Monoisotopic Mass | 243.088469 g/mol |
| Topological Polar Surface Area | 78.9 Ų |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 385 |
| Isotope Atom Count | 1 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
ABOUT THIS PAGE
A Fluorothymidine F-18 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fluorothymidine F-18, including repackagers and relabelers. The FDA regulates Fluorothymidine F-18 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fluorothymidine F-18 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Fluorothymidine F-18 supplier is an individual or a company that provides Fluorothymidine F-18 active pharmaceutical ingredient (API) or Fluorothymidine F-18 finished formulations upon request. The Fluorothymidine F-18 suppliers may include Fluorothymidine F-18 API manufacturers, exporters, distributors and traders.
click here to find a list of Fluorothymidine F-18 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fluorothymidine F-18 DMF (Drug Master File) is a document detailing the whole manufacturing process of Fluorothymidine F-18 active pharmaceutical ingredient (API) in detail. Different forms of Fluorothymidine F-18 DMFs exist exist since differing nations have different regulations, such as Fluorothymidine F-18 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Fluorothymidine F-18 DMF submitted to regulatory agencies in the US is known as a USDMF. Fluorothymidine F-18 USDMF includes data on Fluorothymidine F-18's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fluorothymidine F-18 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Fluorothymidine F-18 suppliers with USDMF on PharmaCompass.
Fluorothymidine F-18 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fluorothymidine F-18 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fluorothymidine F-18 GMP manufacturer or Fluorothymidine F-18 GMP API supplier for your needs.
A Fluorothymidine F-18 CoA (Certificate of Analysis) is a formal document that attests to Fluorothymidine F-18's compliance with Fluorothymidine F-18 specifications and serves as a tool for batch-level quality control.
Fluorothymidine F-18 CoA mostly includes findings from lab analyses of a specific batch. For each Fluorothymidine F-18 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fluorothymidine F-18 may be tested according to a variety of international standards, such as European Pharmacopoeia (Fluorothymidine F-18 EP), Fluorothymidine F-18 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fluorothymidine F-18 USP).
LOOKING FOR A SUPPLIER?
